
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
Authors' Affiliations: Departments of 1 Medicine and Medical Specialties, and 2 Pathology, University of Modena and Reggio Emilia, Modena; 3 Department of Experimental and Diagnostic Medicine, University of Ferrara, 4 Division of Clinical Oncology, St. Anna Hospital, Ferrara; 5 Department of Pathology, University of Verona; 6 Pathology Unit of Civil Hospital of Carpi, Carpi; and 7 Complex Operative Unit of Oncology, Ovest Vicentino, Vicenza, Italy
Requests for reprints: Piero Benatti, Medicine and Medical Specialties, University of Modena and Reggio Emilia, via del Pozzo 71, 41100 Modena, Italy. Phone: 39-59-422-2631; Fax: 39-59-422-2958; E-mail: pbenatti{at}unimo.it.
Purpose: Many studies have evaluated the role of high levels of microsatellite instability (MSI) as a prognostic marker and predictor of the response to chemotherapy in colorectal cancer (CRC); however, the results are not conclusive. The aim of this study was to analyze the prognostic significance of high levels of MSI (MSI-H) in CRC patients in relation to fluorouracil-based chemotherapy.
Experimental Design: In three different institutions, 1,263 patients with CRC were tested for the presence of MSI, and CRC-specific survival was then analyzed in relation to MSI status, chemotherapy, and other clinical and pathologic variables.
Results: Two hundred and fifty-six tumors were MSI-H (20.3%): these were more frequently at a less advanced stage, right-sided, poorly differentiated, with mucinous phenotype, and expansive growth pattern than microsatellite stable carcinomas. Univariate and multivariate analyses of 5-yearspecific survival revealed stage, tumor location, grade of differentiation, MSI, gender, and age as significant prognostic factors. The prognostic advantage of MSI tumors was particularly evident in stages II and III in which chemotherapy did not significantly affect the survival of MSI-H patients. Finally, we analyzed survival in MSI-H patients in relation to the presence of mismatch repair gene mutations. MSI-H patients with hereditary nonpolyposis colorectal cancer showed a better prognosis as compared with sporadic MSI-H; however, in multivariate analysis, this difference disappeared.
Conclusions: The type of genomic instability could influence the prognosis of CRC, in particular in stages II and III. Fluorouracil-based chemotherapy does not seem to improve survival among MSI-H patients. The survival benefit for patients with hereditary nonpolyposis colorectal cancer is mainly determined by younger age and less advanced stage as compared with sporadic MSI-H counterpart.
This article has been cited by other articles:
![]() |
I. Zlobec, K. Baker, L. M. Terracciano, and A. Lugli RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis Clin. Cancer Res., June 15, 2008; 14(12): 3798 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Chan, J. A. Meyerhardt, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, J. Thomas, P. Schaefer, R. Whittom, A. Hantel, et al. Association of Family History With Cancer Recurrence and Survival Among Patients With Stage III Colon Cancer JAMA, June 4, 2008; 299(21): 2515 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Zlobec and A Lugli Prognostic and predictive factors in colorectal cancer J. Clin. Pathol., May 1, 2008; 61(5): 561 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imai and H. Yamamoto Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics Carcinogenesis, April 1, 2008; 29(4): 673 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Weichert, A. Roske, S. Niesporek, A. Noske, A.-C. Buckendahl, M. Dietel, V. Gekeler, M. Boehm, T. Beckers, and C. Denkert Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo Clin. Cancer Res., March 15, 2008; 14(6): 1669 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Newcomb, Y. Zheng, V. M. Chia, L. M. Morimoto, V. P. Doria-Rose, A. Templeton, S. N. Thibodeau, and J. D. Potter Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women Cancer Res., August 1, 2007; 67(15): 7534 - 7539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malesci, L. Laghi, P. Bianchi, G. Delconte, A. Randolph, V. Torri, C. Carnaghi, R. Doci, R. Rosati, M. Montorsi, et al. Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer Clin. Cancer Res., July 1, 2007; 13(13): 3831 - 3839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Boland Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge J. Clin. Oncol., March 1, 2007; 25(7): 754 - 756. [Full Text] [PDF] |
||||
![]() |
J J L Wong, N J Hawkins, and R L Ward Colorectal cancer: a model for epigenetic tumorigenesis Gut, January 1, 2007; 56(1): 140 - 148. [Full Text] [PDF] |
||||
![]() |
J M Carethers Authors' reply. Gut, December 1, 2006; 55(12): 1819 - 1819. [Full Text] [PDF] |
||||
![]() |
R Jover, A Castells, X Llor, and M Andreu Authors' reply. Gut, December 1, 2006; 55(12): 1819 - 1820. [Full Text] [PDF] |
||||
![]() |
B Iacopetta and T Watanabe Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut, November 1, 2006; 55(11): 1671 - 1672. [Full Text] [PDF] |
||||
![]() |
T. Watanabe, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, S. Ishihara, H. Nagawa, P. Benatti, M. Ponz de Leon, R. Gafa, et al. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. Clin. Cancer Res., June 15, 2006; 12(12): 3866 - 3867. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |